| Investigator |
Title |
Sponsor |
ID |
Dates |
Amount |
| David I Bernstein, MD |
Mouse and Guinea Pig Models for Cytomegalovirus and Herp |
National Institutes of Health (NIH) |
HHSN27200003 |
10/31/2019 - 10/29/2020 |
$753,986 |
| Heidi Mills Andersen, MD |
Personalized fecal microbiota transplant in children with cancer |
St. Baldrick's Foundation |
580634 |
07/01/2019 - 06/30/2020 |
$110,000 |
| John J Erickson, MD-PHD |
Maternal microchimerism transfers cellular immunity to offspring |
National Institutes of Health (NIH) |
F32AI145184 |
07/01/2019 - 06/30/2020 |
$72,230 |
| Joseph Edward Qualls, PHD |
L-citrulline and anti-tuberculosis host defense |
National Institutes of Health (NIH) |
R01AI116668 |
07/01/2019 - 06/30/2020 |
$390,000 |
| Koichi Araki DVM |
Translational Regulation of CD8 T-Cell Immunity - Transfer of R01AI139675 from Emory |
National Institutes of Health (NIH) |
7R01AI139675 |
08/01/2019 - 07/31/2020 |
$454,637 |
| Lara Danziger-Isakov, MD-MPH |
Non-Invasive Diagnosis of Pediatric Pulmonary Invasive Mold Infections |
Duke University (National Institutes of Health) |
248445-A031576 |
10/31/2019 - 05/31/2023 |
$2,700 |
| Lara Danziger-Isakov, MD-MPH |
B-Cell Targeted Induction to Improve Outcomes in Pediatric |
Washington University (National Institutes of Health) |
U01IA077810 |
03/01/2017 - 02/29/2020 |
$74,929 |
| Margaret K Hostetter, MD |
PSDP American Pediatric Society Funding |
American Pediatric Society |
PSDP APS |
07/01/2011 - 06/30/2022 |
$134,124 |
| Margaret K Hostetter, MD |
Child Health Research Career Development Award (CHRCDA) Program (K12) |
National Institutes of Health (NIH) |
K12HD028827 |
12/01/2019 - 11/30/2020 |
$424,849 |
| Mary Allen Staat, MD |
Enhanced Surveillance for New Vaccine Preventable Disease |
Ctr for Disease Control and Prevention |
U01IP001059 |
09/01/2019 - 08/31/2020 |
$2,950,000 |
| Mary Allen Staat, MD |
Apnea in Hospitalized Preterm Infants Following the Admi |
Ctr for Disease Control and Prevention |
OOHCVLDE-2018-28077 |
09/15/2018 - 01/14/2021 |
$367,336 |
| Mary Allen Staat, MD |
CISA - LAIV and Asthma Study (Contributing) 200-2012-53661/0004 |
Ctr for Disease Control and Prevention |
00HCVLDE-2018-24194 |
04/01/2018 - 09/29/2020 |
$140,234 |
| Monica Malone McNeal |
PATH-GAT.1736-01617986-CRT agreement with Cincinnati Children's |
PATH Vaccine Solutions (Bill & Melinda Gates Foundation) |
PATH-GAT.1736-016179 |
02/19/2018 - 04/09/2018 |
$100,912 |
| Nancy M Sawtell, PHD |
Forward genetic prediction and testing of virulence loci in herpes simplex virus 1 |
Pennsylvania State University (National Institutes of Health) |
R01AI132692 |
02/01/2019 - 01/31/2020 |
$42,858 |
| Paul W Spearman, MD |
Leadership Group for an Infectious Diseases Clinical Research Consortium (IDCRC) (UM1 Clinical Trial Required) |
Emory University (National Institutes of Health) |
A263440 |
12/01/2019 - 11/30/2020 |
$60,145 |
| Paul W Spearman, MD |
Role of Vpu, Tetherin, and Siglec-1 in HIV-1 Replication |
National Institutes of Health (NIH) |
R01AI150475 |
09/01/2019 - 08/31/2020 |
$408,407 |
| Paul W Spearman, MD |
Viral and Cellular Determinants of HIV-1 Assembly |
National Institutes of Health (NIH) |
R01AI150486 |
02/01/2020 - 01/31/2021 |
$357,750 |
| Robert W Frenck, MD |
International Maternal Pediatric Adolescent AIDS Clinical Trials Group Enrolling Site Project Specific Task Order |
Johns Hopkins School of Medicine (National Institutes of Health) |
PTCL02 |
03/16/2020 - 06/16/2020 |
$47,618 |
| Robert W Frenck, MD |
International Maternal Pediatric Adolescent AIDS Clinical Trials Group Enrolling Site Project Specific Task Order |
Johns Hopkins School of Medicine (National Institutes of Health) |
PTCL02 |
01/01/2018 - 11/30/2019 |
$23,766 |
| Robert W Frenck, MD |
International Maternal Pediatric Adolescent AIDS Clinical Trials Group Enrolling Site Project Specific Task Order |
Johns Hopkins University (National Institutes of Health) |
PTCL 02 |
12/01/2018 - 11/30/2019 |
$19,600 |
| Robert W Frenck, MD |
Vaccine and treatment evaluation units (VTEU) protocol development and implementation task area B-C natural history challenge study for influenza |
National Institutes of Health (NIH) |
18-0010.B1C1.0120 |
04/15/2019 - 08/15/2021 |
$1,175,159 |
| Robert W Frenck, MD |
RTOP FY2020.A1B1C1D10123-HHSN272201300016 |
National Institutes of Health (NIH) |
HHSN272201300016I |
07/12/2019 - 12/31/2020 |
$2,409,087 |
| Robert W Frenck, MD |
Vaccine and Treatment Evaluation Units (VTEUs) (UM1 Clinical Trial Required) |
National Institutes of Health (NIH) |
UM1AI148372 |
12/11/2019 - 11/30/2020 |
$636,246 |
| Robert W Frenck, MD |
A phase 1 randomized, placebo‐controlled, observer‐blind trial to assess the safety and immunogenicity of a Nipah vaccine, HeV‐sG‐V, in healthy adults. |
PATH Vaccine Solutions |
PATH_NIPAH |
12/01/2019 - 04/30/2021 |
$1,025,025 |
| Sing Sing Way, MD-PHD |
HHMI Faculty Scholar Award |
Howard Hughes Medical Institute |
55108587 |
11/01/2019 - 10/31/2020 |
$120,000 |
| Sing Sing Way, MD-PHD |
Maternal Regulatory T cell antigen-specificity |
National Institutes of Health (NIH) |
R01AI120202 |
11/01/2019 - 10/31/2020 |
$390,000 |
| Sing Sing Way, MD-PHD |
Immunological identity redefined by genetically foreign |
National Institutes of Health (NIH) |
DP1AI131080 |
08/01/2019 - 07/31/2020 |
$1,092,000 |
| Sing Sing Way, MD-PHD |
Functional immune tolerance to non-inherited maternal an |
National Institutes of Health (NIH) |
R01AI124657 |
02/01/2020 - 01/31/2021 |
$390,000 |
| Sing Sing Way, MD-PHD |
Progesterone induced immune modulation during pregnancy |
National Institutes of Health (NIH) |
R01AI145840 |
07/01/2019 - 06/30/2020 |
$800,085 |
| Steven Black, MD |
CISA Clinical Vaccine Safety Evaluation - Contributing C |
Ctr for Disease Control and Prevention |
OOHCVLDE-2017-16122 |
09/29/2019 - 09/28/2020 |
$43,421 |
| Xi Jason Jiang, PHD |
A novel lactic acid bacteria-based norovirus vaccine. |
Ohio State University (National Institutes of Health) |
R01AI123661 |
03/01/2019 - 02/29/2020 |
$121,293 |
| Current Year Direct |
$15,138,397 |
